Ropes & Gray Innovation in Asia Sparks High Ranking by the Financial Times

Practices: Global Reach, Life Sciences, China Life Sciences, Private Equity, Capital Markets, Finance, Asia Private Equity, Government Enforcement / White Collar Crime, Business & Commercial Litigation

The Financial Times ranked Ropes & Gray highly in its “Asia-Pacific Innovative Lawyers 2014” report, reflecting the progress the firm has made in the region in a relatively short amount of time. Ropes & Gray was ranked #8 among internationally headquartered firms. We were named a “standout” in international strategy, and work for clients in finance & capital markets, government enforcement, and corporate & commercial also was cited. The report was released June 11.

A feature article in the report highlights Ropes & Gray’s full service approach to life sciences in the region, noting, “The US-headquartered law firm — which is a relative newcomer in the region since its Tokyo debut in 2007 — has scored a standout ranking for its work building a life-sciences practice that offers regulatory, intellectual property and transactional advice.”

The Financial Times also highlights a number of individual transactions and noteworthy “firsts” handled by our teams in Asia, including:  

  • Acting on behalf of the Blackstone-led buyer group consortium to oversee Chinese IT company Pactera’s take-private, using the first leveraged buyout of a US-style bridge-loan-to-bond financing.
  • Supporting Bain Capital in its joint venture with Sumitomo Corp., the first of its kind between a global private equity firm and a Japanese trading company.
  • Counseling AstraZeneca subsidiary MedImmune on its joint venture with WuXi AppTec, China’s largest clinical research organization, which created the first novel biologics joint venture in China.

To read the full report, click here